Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or…
NCT00003072 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00003072 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer |
| Official title | Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Neurotoxicity, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | amifostine trihydrate, carboplatin, paclitaxel |
| Enrollment | 80 |
| Start date | May 1, 1997 |
| Primary completion | Oct 1, 1998 |
| Completion | Oct 1, 1998 |
| First posted | Sep 6, 2004 |
| Last update posted | Sep 21, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: